Potential Impact of Radiation Biology in Radiation Protection in Nuclear Medicine and Corresponding Regulatory Issues

  • Michel H. Bourguignon
Part of the Medical Radiology book series (MEDRAD)


Radiation biology has paved the way to radiation therapy. Modern immunofluorescence techniques are completely transforming radiation biology: individual radiosensitivity is a factor to be taken into account. There is still a gap between abnormalities of DNA lesions signalization and repair pathways and cancer. Better dosimetry is needed for radionuclide therapy. No major changes in radiation protection regulations to be seen in the coming years


Radiation Protection Bystander Effect Nijmegen Breakage Syndrome Radiation Biology Collective Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Azria D, Ozsahin M, Krama A, Peters S, Atencio DP, Crompton NE, Mornex F, Pèlegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS (2008) Single nucleotide polymorphisms, apoptosis and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14:6284–6288PubMedCentralPubMedCrossRefGoogle Scholar
  2. Badie C, Dziwura S, Raffy C, Tsigani T, Alsbeih G, Moody J, Finnon P, Levine E, Scott D, Bouffler S (2008) Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. Br J Cancer 98:1845–1851PubMedCentralPubMedCrossRefGoogle Scholar
  3. BEIR VII (2005) Health risks from exposure to low levels of ionizing radiation: BEIR VII—Phase 2. Committee to assess health risks from exposure to low level of ionizing radiation, National research council. National academies press, WashingtonGoogle Scholar
  4. Belyakov OV, Mitchell SA, Parikh D, Randers-Pehrson G, Marino SA, Amundson SA, Geard CR, Brenner DJ (2005) Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc Natl Acad Sci U S A 102(40):14203–14208PubMedCentralPubMedCrossRefGoogle Scholar
  5. Berrington de Gonzalez A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C (2009) Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 169(22):2071–2077PubMedCrossRefGoogle Scholar
  6. Bourguignon MH, Gisone P, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED (2005a) Genetic and epigenetic features in radiation sensitivity. Part I: cell signalling in radiation response. Eur J Nucl Med Mol Imaging 32:229–246PubMedCrossRefGoogle Scholar
  7. Bourguignon MH, Gisone P, Perez MR, Michelin S, Dubner D, Giorgio MD, Carosella ED (2005b) Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection. Eur J Nucl Med Mol Imaging 32:351–368PubMedCrossRefGoogle Scholar
  8. Brooks AL (2004) Evidence for bystander effects in vivo. Hum Exp Toxicol 23(2):67–70PubMedCrossRefGoogle Scholar
  9. Djordjevic B (2000) Bystander effects: a concept in need of clarification. BioEssays 22(3):286–290PubMedCrossRefGoogle Scholar
  10. Emerit I, Levy L, Cernjavski l, Arutyunyan R, Oganesyan N, Pogosian A, Mejlumian H, Sarkisian T, Gulkandanian M, Quastel M (1994) Transferable clastogenic activity in plasma from persons exposed as salvage personel of the Chernobyl reactor. J Cancer Res Clin Oncol 120(9):558–561PubMedGoogle Scholar
  11. Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65(1):1–7PubMedCrossRefGoogle Scholar
  12. ICRP 44 (1985) Annals of the International commission on radiological protection. Protection of the patient in radiation therapy. JAICRP 15(2)Google Scholar
  13. ICRP 60 (1990) Recommendations of the international commission on radiological protection. JAICRP 21(1–3)Google Scholar
  14. ICRP 79 (1998) Annals of the International commission on radiological protection. Genetic susceptibility to cancer. JAICRP 28(1–2)Google Scholar
  15. ICRP 94 (2004) Annals of the International commission on radiological protection. Release of patients after therapy with unsealed radionuclides. JAICRP 34(2)Google Scholar
  16. ICRP 103 (2007) Annals of the international commission on radiological protection. The 2007 recommendations of the ICRP. JAICRP 37(2–4)Google Scholar
  17. ICRP 105 (2007) Annals of the international commission on radiological protection. Radiological protection in medicine. JAICRP 37(6)Google Scholar
  18. Joiner MC, Marples B, Lambin P, Short SC, Turesson I (2001) Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Biol Phys 49(2):379–389CrossRefGoogle Scholar
  19. Joubert A, Foray N (2007) Intrinsic radiosensitivity and DNA double-strand breaks in human cells. Cancer Radiother 11:129–142PubMedCrossRefGoogle Scholar
  20. Joubert A, Zimmerman K, Bencokova Z, Gastaldo J, Chavaudra N, Favaudon V, Arlett CF, Foray N (2008) DNA double-strand break repair defects in syndromes associated with acute radiation reponse: at least two different assays to predict intrinsic radiosensitivity. Int J Radiat Biol 84:1–19CrossRefGoogle Scholar
  21. Kadhim MA, Mc Donald DA, Goodhead DT, Lorimore SA, Marsden SJ, Wright EG (1992) Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 355(6362):738–740PubMedCrossRefGoogle Scholar
  22. Kassis AI (2004) In vivo validation of the bystander effect. Hum Exp Toxicol 23(2):71–73PubMedCrossRefGoogle Scholar
  23. Lorimore SA, Coates PJ, Wright EG (2003) Radiation-induced genomic instability and bystander effects: inter-related non targeted effects of exposure to ionizing radiation. Oncogene 22(45):7058–7069PubMedCrossRefGoogle Scholar
  24. McIlrath J, Bouffler S, Samper E, McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A, Blasco MA, Newbold RF, Slijepcevic P (2001) Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res 61(3):912–915PubMedGoogle Scholar
  25. Morgan WF (2003a) Non targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res 159(5):567–580PubMedCrossRefGoogle Scholar
  26. Morgan WF (2003b) Non targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res 159(5):581–596PubMedCrossRefGoogle Scholar
  27. Morgan WF (2003c) Is there a common mechanism underlying genomic instability, bystander effects and other non targeted effects of exposure to ionizing radiation? Oncogene 22(45):7094–7099PubMedCrossRefGoogle Scholar
  28. Mothersill C, Seymour CB (1997) Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int J Radiat Biol 71(4):421–427PubMedCrossRefGoogle Scholar
  29. Mothersill C, Seymour CB (2004) Radiation-induced bystander effects—implications for cancer. Nat Rev Cancer 4(2):158–164PubMedCrossRefGoogle Scholar
  30. Mothersill C, Lyng F, Seymour CB, Maguire P, Lorimore S, Wright E (2005) Genetic factors influencing bystander signalling in murine bladder epithelium after low-dose irradiation in vivo. Radiat Res 163(4):391–399PubMedCrossRefGoogle Scholar
  31. Multidisciplinary European Low Dose initiative (MELODI) (2009) Low dose risk research: the MELODI European platform project. http:\\
  32. NIH (2006) New malignancies among cancer survivors. NIH publication N°05-5302, BethesdaGoogle Scholar
  33. Ohba K, Omagari K, Nakamura T, Ikuno N, Saeki S, Matsuo I, Kinoshita H, Masuda J, Hazama H, Sakamoto I, Kohno S (1998) Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 43(4):575–577PubMedCentralPubMedCrossRefGoogle Scholar
  34. Olive PL, Banath JP (2004) Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 58:331–335PubMedCrossRefGoogle Scholar
  35. Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, Sozzi WJ, Zouhair A, Mirimanoff RO, Azria D (2005) CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11:7426–7433PubMedCrossRefGoogle Scholar
  36. Regaud C (1922) Influence de la durée de radiation sur les effets déterminés dans le testicule par le radium. C R Soc Biol 86:878Google Scholar
  37. Rothkamm K, Löbrich M (2003) Evidence for a lack of DNA double strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci U S A 100(9):5057–5062PubMedCentralPubMedCrossRefGoogle Scholar
  38. Sawant SG, Randers-Pehrson G, Metting NF, Hall EJ (2001) Adaptive response and the bystander effect induced by radiation in C3H 10T(1/2) cells in culture. Radiat Res 156:177–180PubMedCrossRefGoogle Scholar
  39. Smith-Bindman R, Lipson J, Marcus R, Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, Berrington de González A, Miglioretti DL (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169(22):2078–2086PubMedCrossRefGoogle Scholar
  40. Tawn EJ, Whitehouse CA, Winther JF, Curwen GB, Rees GS, Stovall M, Olsen JH, Guldberg P, Rechnitzer C, Schrøder H, Boice JD Jr (2005) Chromosome analysis in childhood cancer survivors and their offspring—no evidence for radiotherapy-induced persistent genomic instability. Mutat Res 583(2):198–206PubMedCentralPubMedCrossRefGoogle Scholar
  41. UNESCO (1997) Universal declaration on the human genome and human rights. 29th session of the general conferenceGoogle Scholar
  42. UNSCEAR (2000) Report: sources and effects of ionizing radiation.
  43. UNSCEAR (2006) Report: effects of ionizing radiation.
  44. Zhou H, Randers-Pehrson G, Geard CR, Brenner DJ, Hall EJ, Hei TK (2003) Interaction between radiation-induced adaptive response and bystander mutagenesis in mammalian cells. Radiat Res 160(5):512–516PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg  2012

Authors and Affiliations

  1. 1.Faculty of Medicine of Western ParisUniversity of Versailles—Saint Quentin en Yvelines, Commissioner, The French Nuclear Safety Authority (ASN)Paris Cedex 12France

Personalised recommendations